======= HRASLS2 ======= == Gene Information == * **Official Symbol**: PLAAT2 * **Official Name**: phospholipase A and acyltransferase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54979|54979]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NWW9|Q9NWW9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HRASLS2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HRASLS2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613866|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Exhibits PLA1/2 activity, catalyzing the calcium- independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Catalyzes N-acylation of PE using both sn-1 and sn-2 palmitoyl groups of PC as acyl donor. Also catalyzes O-acylation converting lyso-PC into PC. {ECO:0000269|PubMed:19615464}. |NC| |1-acyl-2-lysophosphatidylserine acylhydrolase activity| |N-acylphosphatidylethanolamine metabolic process| |phosphatidylserine 1-acylhydrolase activity| |N-acyltransferase activity| |phospholipase A1 activity| |phosphatidylethanolamine metabolic process| |phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)| |phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)| |phosphatidylethanolamine acyl-chain remodeling| |phospholipase A2 activity| |phosphatidylcholine metabolic process| |ammonium ion metabolic process| |lipid catabolic process| |glycerophospholipid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |cellular amide metabolic process| |organophosphate metabolic process| |cellular lipid metabolic process| |lipid metabolic process| |organic substance catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp152|SGC2043 10μM R03 exp152]]|1.78| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|1.86| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6584 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}